Brookfield Corp (BN.TO)

Got stopped out at $77. Great company. Private equity is having a difficult time in this market, partly because so many have used leverage for deals and the cost of credit is going up.

A quality Canadian name, allowing Canadian dollars to access global markets. Their challenge is that they invest in private businesses, then sell them at a higher price. But all the current volatility has put those plans on hold. Not the end of the world--BN will continue to run those businesses.

He rotated out a few weeks ago. Seeing recent weakness in financials (with $$ also coming out of industrials and consumer discretionary). Chart shows a fairly major breakdown of support ~$78. Now the stock is rolling back up, so it's looking more encouraging. Downtrend line on the chart is ~$81-82, so we'll have to see what happens at that point.

At Investor day last September it targeted expected distributed earnings at 17% compounded annually over the next 5 years. There's another possible target of 25%. It does not have much exposure to tariffs.

Loves it, wonderful management. Ran up too much, too fast. Not surprised by pullback, as all the private equity firms have. If liquidity tightens up, these guys won't be able to easily sell projects, GAAP earnings will suffer, with lower near-term cashflow and profitability. 

A core holding in his Canadian dividend strategy. Incredibly well run by bright people for a long time. Sold off ~10%, but chart's done extremely well. Likes that CEO has bulk of his net worth invested in shares. Quality operation.

A year ago, people were worried about its exposure to real estate. Management owns 20% of the company, so it behooves them to do well for shareholders. Cashflow monster. Management believes its real estate holdings and potential fees are undervalued.

Are shrewd operators run by a smart CEO. Definitely buy on weakness. He wishes he knew what they own, but they seem to own everything that is great.

Indicated a move of head office to US, but doesn't have to do with tariffs. They're global, yet Canada provides only a small percentage of earnings. Management believes a move would encourage more US-based indices to include it, thereby broadening its potential shareholder base.

Phenomenal compounder. Valuation still at massive discount to US peers. Management closely aligned with shareholders and working hard to unlock value. He'd consider buying today. Unique position with capital allocation to maximize its portfolio.

He doesn't worry too much about tariffs, given BN's geographic diversity and type of operations. Great business, well-positioned long term. Valuation discount not as appealing as in the past. Be mindful of your position size.

Managed well and owns several spin-offs, baby Brookfield stocks. The stock price has moved up a lot in the past year as has the group. But it needs a pause. This is not being negative about BN-T, but the correct stock price offers no safety. You can buy this, put it away and in 5 years shares will likely be higher.

Gets you into the private equity world of alternative investments, without having to hold a mutual fund. You get more liquidity in an individual stock, along with potential growth of M&A. US deregulation should enhance M&A activity, especially if the Fed cuts another half a point. That's why it wanted to move its head office to New York. 

Good allocators of capital. Only issue is that beta is higher, so stock price will be more volatile. Good hold for growth over the long term (whereas BAM provides income to retirees). Yield is 0.5%.

In an uptrend, not parabolic. Right now, it's making a normal pullback to a trendline. Good-looking stock.

Prefers this to BAM, which BN owns as well as many private assets. The CEO holds a lot of stock, too.